Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders

Part of paid clinical trials in Rochester, Minnesota.

Sponsor
Mayo Clinic
Study ID
NCT04680130
Status
Enrolling By Invitation

Conditions

  • Apraxia of Speech
  • Behavioral Variant of Frontotemporal Dementia
  • CBD
  • FTD
  • LPA
  • MSA - Multiple System Atrophy
  • PCA
  • PPA
  • PSP
  • Parkinson Disease
  • Semantic Aphasia
  • Semantic Dementia

Eligibility Criteria

Sex
ALL
Age
21 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • C-11 PiB — DRUG
    Completing PET scan looking for amyloid protein
  • AV1451 Tau — DRUG
    Completing PET scan looking for tau protein
  • C-11 ER176 — DRUG
    Completing PET scan looking for neuroinflammation

Study Details

The investigators aim to learn more about symptoms suggestive of a neurodegenerative process.

Key Dates

Start date
Nov 1, 2020
Status verified
Nov 2025
Primary completion
Nov 30, 2050
Completion
Nov 30, 2050

Study Design

Enrollment
500 participants (estimated)

Arms

  • Arm: Neurodegenerative symptoms

Primary Outcome Measure

Imaging analysis [ Time Frame: 1 year ]

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo ClinicRochesterMinnesota55905-

Find similar trials in Rochester, MN

By condition
Parkinson's disease
By specialty
NeurologyBrain disorders
By research site
Mayo Clinic· Rochester, MN

Related Studies